NUTEX Investments (BUD:NUTEX) Margin of Safety % (DCF FCF Based): N/A (As of Jul. 03, 2026)


BUD:NUTEX NUTEX Investments PLC BUD:NUTEX
50 GF Score
Price Ft13.40
GF Value Ft13.80
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is NUTEX Investments Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

NUTEX Investments's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

BUD:NUTEX vs ZTS, UTHR, VTRS: Margin of Safety % (DCF FCF Based) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, NUTEX Investments's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NUTEX Investments Margin of Safety % (DCF FCF Based) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, NUTEX Investments's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where NUTEX Investments's Margin of Safety % (DCF FCF Based) falls into.


BUD:NUTEX
50GF Score
NUTEX Investments PLC BUD:NUTEX
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is NUTEX Investments (BUD:NUTEX) Overvalued in 2026?

Based on GuruFocus' analysis, NUTEX Investments stock appears to be undervalued. The current stock price of Ft13.40 is trading 2.9% below its estimated GF Value™ of Ft13.80. GuruFocus considers NUTEX Investments to be Fairly Valued.

Key valuation signals for BUD:NUTEX:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: Ft13.80 vs. price of Ft13.40 (2.9% below fair value)
  • GF Score™: 50/100 with 3 warning signs

No single metric tells the full story. See the BUD:NUTEX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

NUTEX Investments Business Description

Address Telepes u. 53., Budapest, HUN, 1147
NUTEX Investments PLC operates as a drug manufacturer in Hungary. The company is engaged in production of products that focuses on health, vitality, and natural ingredients.
50GF Score

Get the complete analysis for BUD:NUTEX

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Ft13.40
Price
Ft13.80
GF Value